Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Term Asphyxiated Neonates during Controlled Therapeutic Hypothermia

Autor: Marlotte A. A. van der Veer, Timo R. de Haan, Linda G. W. Franken, Caspar J. Hodiamont, Floris Groenendaal, Peter H. Dijk, Willem P. de Boode, Sinno Simons, Koen P. Dijkman, Henrica L. M. van Straaten, Monique Rijken, Filip Cools, Debbie H. G. M. Nuytemans, Anton H. van Kaam, Yuma A. Bijleveld, Ron A. A. Mathôt, Mieke J. Brouwer, Marcel P. van den Broek, Carin M. A. Rademaker, Djien Liem, Katerina Steiner, Sinno H. P. Simons, Annelies A. Bos, S. M. Mulder-de Tollenaer, L. J. M. Groot Jebbink-Akkerman, Michel Sonnaert, Fleur Anne Camfferman

Publikováno v: Antimicrobial Agents and Chemotherapy, 67, 5
Antimicrobial agents and chemotherapy, 67(5). American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 67

Item does not contain fulltext Ceftazidime is an antibiotic commonly used to treat bacterial infections in term neonates undergoing controlled therapeutic hypothermia (TH) for hypoxic-ischemic encephalopathy after perinatal asphyxia. We aimed to desc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c36409b9469e5a370bf44dc11974469
https://repository.ubn.ru.nl/handle/2066/292923